Article ; Online: Effect of erythropoietin on cognitive side-effects of electroconvulsive therapy in depression: A randomized, double-blind, placebo-controlled trial.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
2023 Volume 79, Page(s) 38–48
Abstract: Electroconvulsive therapy (ECT) is one of the most effective and rapid-acting treatment for severe depression but is associated with cognitive side-effects. Identification of add-on treatments that counteract these side-effects would be very helpful. ... ...
Abstract | Electroconvulsive therapy (ECT) is one of the most effective and rapid-acting treatment for severe depression but is associated with cognitive side-effects. Identification of add-on treatments that counteract these side-effects would be very helpful. This randomized, double-blinded, placebo-controlled, parallel-group study investigated the effects of four add-on erythropoietin (EPO; 40,000 IU/ml) or saline (placebo) infusions over 2.5 weeks of ECT (eight ECT sessions) in severely depressed patients with unipolar or bipolar depression. Neuropsychological assessments were conducted pre-ECT, three days after the eighth ECT (week 4), and at a 3-month follow-up. Further, functional magnetic resonance imaging (fMRI) was conducted after the eighth ECT. The primary outcome was change from pre- to post-ECT in a 'speed of complex cognitive processing' composite. Secondary outcomes were verbal and autobiographical memory. Of sixty randomized patients, one dropped out before baseline. Data were thus analysed for 59 patients (EPO, n = 33; saline, n = 26), of whom 28 had fMRI data. No ECT-related decline occurred in the primary global cognition measure (ps≥0.1), and no effect of EPO versus saline was observed on this outcome (ps≥0.3). However post-ECT, EPO-treated patients exhibited faster autobiographical memory recall than saline-treated patients (p = 0.02), which was accompanied by lower memory-related parietal cortex activity. The absence of global cognition changes with ECT and EPO, coupled with the specific impact of EPO on autobiographical memory recall speed and memory-related parietal cortex activity, suggests that assessing autobiographical memory may provide increased sensitivity in evaluating and potentially preventing cognitive side-effects of ECT. TRIAL REGISTRATIONS: ClinicalTrials.gov: NCT03339596, EudraCT no.: 2016-002326-36. |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
MeSH term(s) | Humans ; Electroconvulsive Therapy/adverse effects ; Electroconvulsive Therapy/methods ; Depression ; Treatment Outcome ; Erythropoietin/therapeutic use ; Erythropoietin/pharmacology ; Epoetin Alfa ; Cognition ; Double-Blind Method | ||||||||||
Chemical Substances | Erythropoietin (11096-26-7) ; Epoetin Alfa (64FS3BFH5W) | ||||||||||
Language | English | ||||||||||
Publishing date | 2023-12-20 | ||||||||||
Publishing country | Netherlands | ||||||||||
Document type | Randomized Controlled Trial ; Journal Article | ||||||||||
ZDB-ID | 1082947-7 | ||||||||||
ISSN | 1873-7862 ; 0924-977X | ||||||||||
ISSN (online) | 1873-7862 | ||||||||||
ISSN | 0924-977X | ||||||||||
DOI | 10.1016/j.euroneuro.2023.12.004 | ||||||||||
Shelf mark |
|
||||||||||
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 3288: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MO 630: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.